Teva Branded Pharmaceutical Products R&D, Inc.

17 marketed · 34 in Phase 3

Quick facts

Founded1901

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Teva Branded Pharmaceutical Products R&D, Inc.

What are Teva Branded Pharmaceutical Products R&D, Inc.'s marketed drugs?

Top marketed products include ABS, Albuterol eMDPI DS, Albuterol-HFA-BAI, Albuterol-HFA-MDI, Depo-subQ Provera, desogestrel/ethinyl estradiol.

What is Teva Branded Pharmaceutical Products R&D, Inc.'s pipeline?

Teva Branded Pharmaceutical Products R&D, Inc. has 34 drugs in Phase 3, 15 in Phase 2, 15 in Phase 1. Late-stage candidates include ACR16, albuterol aerosol by HFA BOI, albuterol aerosol by HFA MDI, Albuterol MDPI.

When was Teva Branded Pharmaceutical Products R&D, Inc. founded?

Teva Branded Pharmaceutical Products R&D, Inc. was founded in 1901.

How many employees does Teva Branded Pharmaceutical Products R&D, Inc. have?

Teva Branded Pharmaceutical Products R&D, Inc. has approximately 42,535 employees.

Related